In a surprising move, Ramzi Haidamus stepped down from his post as president of Nokia Technologies, the Silicon Valley division of Finland-based Nokia Group. Nokia Technologies does not yet have someone to replace Haidamus, and the company says he will stick around until the end of September. In the meantime, Brad Rodrigues, who is currently head of strategy and business at the company, will become acting president.
Nokia Technologies was created two years ago with aim of getting Nokia (fresh from selling its mobile handset business to Microsoft) back into the consumer technologies game. Haidamus was hired from Dolby Laboratories to steer the ship, and managed to create a Digital Media business whose first product was the Ozo, a virtual reality camera, and the Digital Health group, which acquired French connected health company Withings earlier this year.
Healthcare data and analytics company Health Catalyst has brought David Grauer to the team, where he will serve as the senior vice president. Previously, Grauer held numerous executive positions in Utah-based not-for-profit system Intermountain Healthcare. Grauer was the the CEO and administrator of Intermountain Medical Center, the largest hospital in Utah and the flagship of Intermountain, and also held the same positions at two other hospitals in the system. Grauer also served on the boards of several community organizations in the Salt Lake City area and is a recipient of the American College of Healthcare Executive’s Regent’s Award.
“David is a highly experienced healthcare leader who has successfully led a true transformation in the quality and efficiency of operations within one our nation’s best healthcare organizations,” Dan Burton, CEO of Health Catalyst said in a statement. “We are thrilled that he has agreed to join our leadership team, where his expertise will be invaluable in helping the company execute on its strategic imperatives in the years ahead.”
Fitbit appointed Des Power as managing director to lead its new Dublin, Ireland office. Power will be responsible for expanding the company’s presence across the region, and has over three decades’ worth of experience leading teams in Europe, the Americas and China. Previously, Power held various leadership roles at Philips and Harman International.“I’m excited to welcome Des to the team and back to his native Ireland,” Fitbit CEO James Park stated. “I have great confidence in our ability to further expand our business and help people across EMEA lead healthier, more active lives.”
Smart inhaler company Adherium announced two new hires: Thomas Lynch, who will serve as chairman, and Dr. Doug Wilson, who will be Adherium's executive medical director. Wilson, who is stepping down from Adherium's board to work in the new capacity, will work with the management team to assist in steering the company's clinical development and strategic path for the next phase of growth. Lynch, who has extensive biotech and specialty pharma experience, just stepped down from Icon, a large clinical research organization. He is also chair of two privately held biotechnology companies, Evofem Biosciences and Profectus Biosciences, and he serves as non-executive director of GW Pharma.
Pharmaceutical company Daiichi Sankyo appointed Dr. Marielle Cohard-Radice as executive vice president and global head of development. Previously, she served as vice president of clinical development operations at the company. In her new role, Cohard-Radice will have responsibility for the development strategy and portfolio planning for the cardiovascular-metabolism and international medicine therapeutic areas. Prior to joining Daiichi Sankyo, Cohard-Radice held positions at Aptalis Pharma, Axcon Pharma, Novartis Pharmaceutical and Schering Plough Research Institute. In these roles, Cohard-Radice built in-depth expertise in global leadership, strategic decision-making for clinical development and operations, medical affairs and drug safety in multiple therapeutic areas.
